co.don AG Share Price Xetra

Equities

DE000A289AA9

Pharmaceuticals

Delayed Xetra 5-day change 1st Jan Change
- EUR -.--% Intraday chart for co.don AG -22.22% -.--%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site

Financials

Sales 2020 6.23M 6.75M 526M Sales 2021 9.8M 10.62M 828M Capitalization 33.89M 36.72M 2.86B
Net income 2020 -13M -14.09M -1.1B Net income 2021 -9M -9.75M -760M EV / Sales 2020 6.74 x
Net cash position 2020 3.15M 3.41M 266M Net cash position 2021 293K 318K 24.74M EV / Sales 2021 3.43 x
P/E ratio 2020
-2.91 x
P/E ratio 2021
-3.8 x
Employees -
Yield 2020 *
-
Yield 2021
-
Free-Float 38.31%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Investor Relations Contact - -
Members of the board TitleAgeSince
Chairman - 28/11/05
Director/Board Member - 06/07/10
More insiders
Co.don AG is a Germany-based company that is active in the tissue engineering and regenerative medicine industry. The Company manufactures cell-based biological drugs for the use in orthopedic and neurosurgical applications. Its products are used for the treatment of focal particular cartilage defects, lumbar disc herniation, non-union fractures and dental disorders. Those include co don chondrotransplant, which is used for cartilage treatment, particularly in the knee area; co don chondrosphere, which is a three-dimensional articular cartilage cultivated outside of the body; co don chondrotransplant DISC, for the regeneration of intervertebral discs, and co don osteotransplant DENT, which is an autologous bone cell transplant for dental applications. The Company is active domestically and in other European countries.
More about the company

Annual profits - Rate of surprise

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW